Pentylenetetrazole , 98% , 54-95-5

Synonym(s):
α,β-Cyclopentamethylenetetrazole;1,5-Pentamethylenetetrazole;6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine;Metrazole

CAS NO.：54-95-5

Empirical Formula: C6H10N4

Molecular Weight: 138.17

MDL number: MFCD00005939

EINECS: 200-219-3

PRODUCT Properties

• Melting point: 59-61 °C (lit.)
• Boiling point: 194 °C/12 mmHg (lit.)
• Density: 1.0617 (rough estimate)
• refractive index: 1.4910 (estimate)
• Flash point: 194°C/12mm
• storage temp.: -20°C
• solubility: ≥15.38 mg/mL in EtOH; ≥6.3 mg/mL in DMSO; ≥83.2 mg/mL in H2O
• form: solid
• pka: 1.25±0.20(Predicted)
• color: White, crystalline powder
• Sensitive: Hygroscopic
• Merck: 14,7141
• BRN: 135492
• Stability: Stable. Incompatible with strong oxidizing agents.
• InChIKey: CWRVKFFCRWGWCS-UHFFFAOYSA-N

Description and Uses

Pentylenetetrazole (PTZ) is a central nervous system modulator that is used to experimentally induce seizures in animals. Subcutaneous PTZ has been used extensively to screen for compounds that block the production of nonconvulsive (absence or myoclonic) seizures. PTZ has diverse, site-specific effects in the brain. However, it is an antagonist of GABA_A receptors and some drugs that block PTZ-induced seizures, including benzodiazepines, act at the GABA_A receptor.

Pentylenetetrazole has been used to induce seizures in zebra fish larvae, mice, and male wistar rats.

Safety

• Symbol(GHS): GHS06
• Signal word: Danger
• Hazard statements: H301-H315-H319-H335
• Precautionary statements: P301+P310+P330-P302+P352-P305+P351+P338
• Hazard Codes: T
• Risk Statements: 25-36/37/38-23/24/25
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 2811 6.1/PG 3
• WGK Germany: 3
• RTECS: XF8225000
• TSCA: Yes
• HazardClass: 6.1
• PackingGroup: II
• Toxicity: LD50 in rats (mg/kg): 85±2 s.c., 62 i.p. (Goldenthal)